TY - JOUR
T1 - The Back2School modular cognitive behavioral intervention for youths with problematic school absenteeism
T2 - Study protocol for a randomized controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services 17 Psychology and Cognitive Sciences 1701 Psychology
AU - Thastum, Mikael
AU - Johnsen, Daniel Bach
AU - Silverman, Wendy K
AU - Jeppesen, Pia
AU - Heyne, David A
AU - Lomholt, Johanne Jeppesen
PY - 2019/1/8
Y1 - 2019/1/8
N2 - Background: School absenteeism (SA) is associated with anxiety, depression, and disruptive behavior. It is a risk factor for academic difficulties and school dropout, which predict problems in adulthood such as social, work-related, and health problems. The main goal of this study is to examine the initial effectiveness of a modular transdiagnostic cognitive behavioral therapy (CBT) intervention (Back2School) for increasing school attendance and decreasing psychological problems, relative to a comparator control arm (treatment as usual [TAU]). Methods/design: One hundred sixty children, aged 7 to 16 years, will be randomly assigned to either Back2School or TAU. The design is a two (Back2School and TAU) by four (preassessment [T1], postassessment [T2], and 3-month [T3] and 1-year [T4] assessments) mixed between-within design. The primary outcome is school attendance based on daily registration. Secondary outcomes pertain to youth psychosocial functioning, quality of life, bullying, self-efficacy, and teacher-parent collaboration. These secondary outcomes are measured via youth, parent, and teacher reports. Discussion: This study will provide critically needed empirical evidence on the initial effectiveness of a manualized treatment program for youth with SA. If the intervention is found to be effective, the program can be further implemented and tested in a larger school health effectiveness trial. Trial registration: ClinicalTrials.gov, NCT03459677. Retrospectively registered on 9 March 2018.
AB - Background: School absenteeism (SA) is associated with anxiety, depression, and disruptive behavior. It is a risk factor for academic difficulties and school dropout, which predict problems in adulthood such as social, work-related, and health problems. The main goal of this study is to examine the initial effectiveness of a modular transdiagnostic cognitive behavioral therapy (CBT) intervention (Back2School) for increasing school attendance and decreasing psychological problems, relative to a comparator control arm (treatment as usual [TAU]). Methods/design: One hundred sixty children, aged 7 to 16 years, will be randomly assigned to either Back2School or TAU. The design is a two (Back2School and TAU) by four (preassessment [T1], postassessment [T2], and 3-month [T3] and 1-year [T4] assessments) mixed between-within design. The primary outcome is school attendance based on daily registration. Secondary outcomes pertain to youth psychosocial functioning, quality of life, bullying, self-efficacy, and teacher-parent collaboration. These secondary outcomes are measured via youth, parent, and teacher reports. Discussion: This study will provide critically needed empirical evidence on the initial effectiveness of a manualized treatment program for youth with SA. If the intervention is found to be effective, the program can be further implemented and tested in a larger school health effectiveness trial. Trial registration: ClinicalTrials.gov, NCT03459677. Retrospectively registered on 9 March 2018.
KW - Absenteeism
KW - Adolescent
KW - Child
KW - Child Behavior Disorders/therapy
KW - Cognitive Behavioral Therapy/methods
KW - Humans
KW - Outcome Assessment (Health Care)
KW - Quality of Life
KW - Randomized Controlled Trials as Topic
KW - Research Design
KW - Cognitive behavioral therapy
KW - Randomized controlled trial
KW - Transdiagnostic
KW - School absenteeism
UR - http://www.scopus.com/inward/record.url?scp=85059756137&partnerID=8YFLogxK
U2 - 10.1186/s13063-018-3124-3
DO - 10.1186/s13063-018-3124-3
M3 - Journal article
C2 - 30621787
SN - 1745-6215
VL - 20
JO - Trials
JF - Trials
IS - 1
M1 - 29
ER -